Showing results (41-50 of 157) with videos related to
Sort By:
Pageof 16
Journal of Surgical Oncology|January 30, 2002
Tumor p16M is a possible marker of advanced stage in non-small cell lung cancerCalvin S H Ng, Jun Zhang, Song Wan, et al.Asia-Pacific Journal of Clinical Oncology|August 18, 2012
Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland ChinaYi-Long Wu, Da-Tong Chu, Baohui Han, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015)Tony Mok, Vera Gorbunova, Erzsebet Juhasz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2014
Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancerCorey J Langer, Silvia Novello, Keunchil Park, et al.JAMA Oncology|December 23, 2017
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysisChee Khoon Lee, Johnathan Man, Sally Lord, et al.European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|November 25, 2010
Piloting electronic self report symptom assessment - Cancer (ESRA-C) in Hong Kong: a mixed method approachCarmen W H Chan, Wilson Tam, Karis K F Cheng, et al.Frontiers in Oncology|November 12, 2025
A comparison of clinical guidelines, treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North AmericaChi-Lu Chiang, Ross Andrew Soo, Tony Mok, et al.Cancer Treatment Reviews|May 11, 2024
NTRK gene fusion testing and management in lung cancerMatteo Repetto, Marina Chiara Garassino, Herbert H Loong, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2011
Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancerKoichi Goto, Yukito Ichinose, Yuichiro Ohe, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 30, 2016
First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain MetastasesMartin Schuler, Yi-Long Wu, Vera Hirsh, et al.Pageof 16